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l Introduction
Liver diseases during pregnancy comprise an im-
portant area of common interest for both peri-
natologists and internists.
On the basis of my own practical experiences and
from an extensive review of the literature which
by necessity includes the presentation of at times
contrasting views of unsatisfactorily resolved
Problems, I am attempting to give a review of the
current knowledge.
In liver disease äs in disease of other Organs during
pregnancy there are essentially two questions:
1. How is the diseased organ, i.e. the liver influenced
by pregnancy — will there be an improvement or
deterioration of the disease?
2. What influence has the liver disease on the
pregnancy, e.g. in reference to malformations,
abortions, prematurity, and perinatal mortality?
2 Changes during normal pregnancy
Every pregnancy is a stress for the entire organism.
While the cardiac Output increases by 40—50%,
the minute volume through the liver rejnains at
11/2 liters/minute. Thus, the relative perfusion of
the liver of normally 35% of the cardiac Output
decreases during pregnancy to 20—25% [22, 27,
37, 77]. Pregnancy poses for the normal liver a
functional stress whichistolerated withoutproblems
by the normal liver.
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Histologicaliy there are no changes specific to
pregnancy in light nor electron microscopy; there
are only variances of nuclear size, an increased
glycogen content and occasional fat deposition in
a few liver cells, especially in the lobular centers
[22,27, 28,60].
The metabolic stress on the liver from the pregnancy
is expressed in some findings deviating from the
norm. The Interpretation of these changes which
are physiologic during pregnancy but abnormal at
other times, poses difficulties for the clinician and
makes the differential diagnosis of liver disease
during pregnancy difficult. (Tab. I :eviews the bio-
chemical changes during normal pregnancy.
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Tab. I. Biochemical changes in normal pregnancy





























During the entire pregnancy the serum protein
concentration is decreased. This is a genuine dys-
proteinemia rather than a dilution from the
hydremia of pregnancy. Until delivery the protein
contents falls continuously to levels under 6 g%
[37].
Because the albumin decreases and the a- and 0-
globulines increase, the albumin/globulin ratio
decreases from 1.32 before pregnancy to 0.7 at
the low point of protein changes on the 4th—6th
postpartum day. The -globulins also slightly
decreased. These changes of the serum protein
composition lead to an increased Sedimentation
rate from the second month of pregnancy on. Co-
agulation and fibrinolysis are changed typically
during pregnancy. During pregnancy the physio-
logical Inhibitors of fibrinolysis are increased, the
total fibrinolytic activity is slightly reduced [65].
Most coagulation factors, especially fibrinogin,
factors VII, VIII, IX, and X are increased. This
results in an increased induction of soluble fibrin
monomer complexes. The presence of these
soluble fibrin monomer complexes in addition to
the increase in activity concentration of some
plasma coagulation factors is responsible for the
slight hypercoagulability during normal pregnancy
[53]. The number of platelets is unchanged during
normal pregnancy and there are no physiological
disturbances of platelet function [44]. The serum
bilirubin level is usually in the normal ränge or
maybe slightly increased because of the greater
hemoglobin turnover. It has now been established
that bilirubin can pass through the placenta [56].
Tab. II revie ws the serum enzymes during pregnancy
[16].
Tab. II. Serum enzymes in pregnancy









































































































* The mean probabüities of eiror are between 0.01 and
0.0005.
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Alkaline phosphatase (AP), a mixture of various
isoenzymes from liver, bone, small bowel and
placenta, markedly increases during pregnancy es-
pecially after the sixth month; it drops sharply 24
hours postpartum and is still slightly above normal
on the sixth postpartum day [37]. The activity of
alkaline phosphatase duringlate pregnancy is mostly
due to the placenta-derivedheat-stable phosphatase
portions[37,41,57].
Gamma-glutamyl-transpeptidase ( - GT), which
occurs along the intra/and extrahepatic bile ducts
and is localized in the mitochondria, is the most
sensitive test for cholestasis [55]. This enzyme also
is increased normally during pregnancy from the
sixth pregnancy month on [16].
Leucine-amino-peptidase (LAP) is more specific
than the alkaline phosphatase and it is markediy
elevated in cholestasis together with 7 — GT [15].
It is also increased during the last month of normal
pregnancies [77]. The transaminases SGOT and
SGPT are the most specific indicators for hepato-
cellular destruction [9, 37, 55]. Since the integrity
of liver cells during pregnancy is generally not
compromised SGOT and SGPT remain normal
during uncomplicated pregnancies. The data from
304 normal pregnant women illustrated in Fig. 2
show a slight increase of these enzymes during the
last threemonths of pregnancy [ 16]. During delivery
and during the first few days postpartum a slight
increase in SGOT and SGPT may be observed [27].
Enzymes indicating necrosis include lactate de-
hydrogenase (LDH), a relatively nonspecific
enzyme, which occurs in addition to liver also in
the cardiac and skeletal muscles [55]. From Tab. II
a slight increase of LDH in the last two months of
pregnancy may be noted [16].
Of interest are enzyme examinations in newborns
24 hours after birth. As an expression of liver cell
necrosis in the newborn after fetal heart rate
decelerations during birth and after protracted
deliveries with the assumption of hypoxic states,
there is a significant increase of LDH, SGOT, SGPT
and especially GLDH activity [54].
Among the so-called liver function tests during
pregnancy only the bromosulfophthalein test (BSP)
has a certain validity. The BSP retention after 45
minutes should not exceed 8% in a normal preg-
nancy [22, 26, 42], It is markedly increased in
cholestasis [55].
In more than 60% of pregnancies the so-called
cutaneous liver signs such äs palmar erythema or
spider nevi occur [23]. They are not an expression
of liver disease but rather due to the increased
estrogen concentration and its vasodilatory effects.
These cutaneous liver signs regress completely
within 4-6 weeks after delivery.
3 Review of liver diseases during pregnancy
Little can be said äs to the prevalence of anicteric
liver disease during pregnancy, since in the absence
of jaundice äs lead Symptom an unknown number
of liver diseases is not recognized [23]. It has been
surmised that during pregnancy, too, anicteric ill-
nesses are more common than icteric ones [45].
Obviously, icteric liver diseases during pregnancy
are much better studies and described [23, 30, 37].
Basically, any icteric illness may occur during
pregnancy. These cases represent the random co-
existence of pregnancy and liver disease. These,
therefore, are referred to äs icterus in graviditate.
In addition, there are liver diseases caused by the
pregnancy itself. These have been designated äs
icterus e graviditate, namely, icterus äs a con-
sequence of pregnancy.
Large case collections indicate a prevalence of
icterus during pregnancy between .2 and 1.8 per/
1000 [28, 30, 33, 45]. Thus, jaundice during
pregnancy is a relatively rare Symptom.
Of interest is a review by HAEMMERLI (Tab. III)
about the incidence of varying forms of icterus,
based on 456 cases [34]. A classification of icteric
mothers during pregnancy is seen in Tab. IV.
I will now describe separately the severe diseases
summarized in Tab. IV. The interaction of liver
disease in pregnancy will be emphasized and the
question of a possibly necessary termination of
pregnancy will be reviewed with each disease.
3. l Icterus in graviditate
3.1.1 Viral Hepatitis
Hepatitis is one of the most common infectious
diseases with about 100,000 to 150,000 cases per
J.Perinat.Med. 7(1979)
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Tab. III. Distribution of important causes of jaundice
during pregnancy [34]
I. Icterus in graviditate: 58.8%
of these:
acute Hepatitis 41.2%
extrahepatic cholestasis (gallstones, etc) 5.9%
other forms (chronic hepatitis, liver cirrhosis) 11.7%
II. Icterus e graviditate: 34.9%
of these:
cholestasis of pregnancy 20.5%
acute fatty liver of pregnancy 0.4%




Tab. IV. Etiology of jaundice during pregnancy
I. Icterus in graviditate
1. Acute viral hepatitis
2. Chronic forms of hepatitis and cirrhosis
3. Rare forms of jaundice
a. intrahepatic cholestasis (e.g. drug-induced jaundice)
b. extrapehatic cholestasis (e.g. gallstones)
c. functional hyperbilirubinemia
d. hemolytic jaundice
e. jaundice with septicemia (severe pyelonephritis,
septic abortion with endotoxin shock)
II. Icterus e graviditate
1. Cholestasis of pregnancy (idiopathic jaundice of
pregnancy)
2. Acute fatty liver of pregnancy
3. Toxemia of pregnancy (hyperemesis, pre-eclampsia,
eclampsia)
year in West Germany with a population of 60
million people. The highest case rate is seen in
children under 15 years and in young adults; thus,
it includes the early reproductive age ränge. Acute
hepatitis is a clinical syndrome caused by infection
with hepatitis virus A and B. The discovery of HBS-
Ag (Australia antigen) in 1965 by BLUMBERG [8]
solved one of the main problems of hepatitis
research, namely, a Serologie classification äs to
the differentiation of the two infections. Demon-
stration of HBs-Ag in blood indicates an acute
infection with the hepatitis B virus. Thus, the
Australia antigen, or HBs-Ag, is an indicator for
the presence of hepatitis B virus [15]. For hepatitis
B there are three separate antigens with numerous
sub-types of which the so-cqlled Australia antigen
is the most thoroughly investigated.
Since, it has become possible to serologically
document hepatitis A infection there have been
indications that there are additional hepatitis
organisms, so-called C or non-A-non-B-virus. This
"non-A-non-B hepatitis" has become the most
common form of post-transfusion hepatitis in the
USA. The existence of at least two of these viruses
has been discussed,however, there are no laboratöry
tests for the identification at this time.
For clarification, the various nomenclatures used
over the years are given in Tab. V with the older
designations in parentheses.
The transmission of hepatitis A occürs primarily by
the fecal-oral route. Transmission may also occur
parenterally during the viremic stage. Transmission
of hepatitis B virus occurs predominately parenter-
ally, though recently it has been recognized that
transmission is also possible by sputum or sexual
'contact. However, these alternate transmission
pathways have no major impörtance. Quantitative
analysis has shown that it takes 10—100 liter saliva
or 1—10 tons of urine or sweat to accumulate the
amounts of HSsAg contained in l ml serum [15].
Incubation time for hepatitis virus A is 2—6 weeks,
for virus B 2—6 months. There is immunity against
reinfection of the same type but no cross immunity.
New studies have shown that infection with one
antigen subtype confersno immunity against disease
with another subtype.
A description of the illness, laboratöry findings,
immunological aspects, and therapy will not be
given in this obstetrically oriented discussion [4, 6,
Tab. V. Nomenclature of various types of hepatitis
Viral hepatitis type A = viral hepatitis A =? VHA = hepatitis
A = HA (Infectious hepatitis = IH = hepatitis infectiosa
= HI = epidemic jaundice = short incubation time
hepatitis). The organism is designated äs hepatitis A
virus - HAV
Viral hepatitis type B = virus hepatitis B = VHB = hepatitis
B = HB (serum hepatitis = SH = homologous serum
icterus = long incubation time hepatitis).
The organism is designated äs Hepatitis B virus = HBV
Viral hepatitis type C = virus hepatitis C
The organism is designated äs non-A-non-B-virus
J. Perinat. Med. 7 (1979)
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12, 31,43, 55, 70]. The susceptibüity for Hepatitis
is - in contrast to older opinions - not different
during pregnancy [37]. Hepatitis may'occur during
all phases of pregnancy. In one review [75] Hepatitis
was found in 13% during the first trimester, in
31% in the second, and in 56% in the third tri-
mester.
If hepatitis begins during late-pregnancy, during
or after birth several authors have seen a more
severe course which converts into the chronic form,
than in a comparison group in the same age [11,
22,32]. However, other authors reported that there
were no differences in duration, severity, and fatal
outcome of the illness during pregnancy; some
even have stated that the course is milder and
shorter [l, 4, 33, 45]. The mortality of hepatitis
during pregnancy in this geographic area is not
different than the mortality from hepatitis of an
unpregnant woman of the same age [l, 33,45, 50].
Severe cases and high mortality have always been
observed if additional risk factors were present
[2, 11, 17], Data from developing countries in
Asia and Africa with poor nutritional conditions
indicate a maternal mortality of 50—70%. The
assumption might be justified that the protein
malnutrition during the increased need for protein
during pregnancy has an unfavorable influence on
the course and outcome of the hepatitis [37].
Proven pathways of the infection with hepatitis
on the infant are oral-fecal postpartum, hemato-
genous infection if the infant is injured during
birth, the maternal-fetal microtransfusion in the
presence of the placental lesion, and colostrum.
A transplacental transmission of hepatitis virus
or HB-Ag must be assumed [5, 11, 14, 48, 66]. If
the maternal disease occurs during the first tri-
mester the fetal case rate is very low [66]. Evidently
during the clinical maternal illness the placental
foci are attacked by maternal antibodies before
infection of the fetus itself [72]. The risks for
neonatal infection increases the closer the maternal
hepatitis infection occurs to the delivery date [66,
67]. With illness during the third trimester until
two months postpartum HB-Ag presence in the
newborn in 70—80% can be shown [66]. Maternal
jaundice regardless of the etiology has no special
influence on the fetus because infants of icteric
mothers are usually born without marked jaundice.
Because of itsprotein-bindingbilirubin presumably
passes only poorly the placental barrier [52]. Data
on the incidence of abortions vary between reports
of no increase [39, 75] and 25% [72] in manifest
maternal hepatitis during the first trimester. Simi-
larly, figures on the incidence of stillbirths vary,
with the highest being given äs 22.8% [69].
Generally, the rate of stillbirths following hepatitis
in the first and second trimester does not differ
from that in other pregnancies [36, 39, 75] while
stillbirths after hepatitis in the third trimester
defmitely are increased [75].
By contrast there is a definite increase of pre-
maturity to 15—35%, especially with disease in
the third trimester [36, 37, 39, 72, 75]. The in-
cidence of prematurity is the same in infected
fetuses or in HB-Ag negative newborns [66, 67].
It is unknown whether this marked increase of
prematurity is due to the acute maternal disease
or due to the direct effect of the virus on the fetus
or placenta.
There is some indication that the premature onset
of labor is due to another mechanism because
jaundice during pregnancy regardless of its etiology
pre-disposes for prematurity [37]. In addition to a
disturbance of the metabolism of placental hor-
mones the increase in bile acids and fatty acids
might lead to an increased tone of the uterus
muscle and thus trigger premature labor [45].
As a consequence of the increased incidence of
prematurity, perinatal mortality is increased,
primarily postpartum mortality. This is equally
true for hepatitis äs for all other liver diseases
associated with jaundice. The prevention of
prematurity in diseases associated with icterus is
an urgent obstetrical problem. Tocolytic drugs of
the beta-mimetic type are not absolutely contra-
indicated in liver disease. However, if the estimated
fetal weight is above 2000 grams one should not
necessarily insist on tocolysis because, given the
current progress in neonatal pediatrics, these
children have a good to excellent extra-uterine
survival chance, especially after fetal lung maturity
has been stimulated.
On the other hand RICHTER and WIEST [63] con-
sider hepatitis äs a contra-indication for tocolysis
because the metabolic action of beta-mimetic
additional stress the heptic metabolism. Whether
J. Perinat. Med. 7(1979)
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this is also valid for cholestatic icterus of pregnancy
has not been defined.
Because of the possibility for neonatal infection
and the additional stress of the mothers, they
should not nurse the infant [13,37].
The incidence of intrauterine growth retardation
and dysmaturity is not increased with hepatitis
[36].
There has been much discussion on the possible
association between viral hepatitis and fetal mal-
formations. According to TÖNDURY there can be
no question about the occurance of embryonal
disturbances from the hepatitis virus. However, a
specific syndrome of hepatitis embryopathy has
not been described [73]. A number of case reports
can be found about malformations in infants
whose mothers contracted viral hepatitis during
early pregnancy. In a large number of these case
reports the correlation appears doubtful [37].
Assuming an incidence of malformation of 2—3%
in the general population the malformation rate
of 3.5% found in series of 528 cases is not signif-
icantly increased [20, 21]. Another series of 555
pregnant women with hepatitis yielded a mal-
formation rate of only 2.6% [39]. Some authors
have cited an association between viral hepatitis
and mongolism äs indication for virus-induced
chromsomal changes; however, this has not been
proven beyond doubt to date [37,48, 71, 77].
A special Situation occurs if the conception occurs
at the time of an acute viral hepatitis. During this
phase of hepatitis, cell cultures of peripheral
lymphocytes show a 7-fold increased rate of ab-
normalities with Australia antigen positive hepatitis
and a 2-fold increase in patients with Australia
antigen negative hepatitis [74]. No practical con-
sequence can be derived from these fmdings nor
from the fact that hematogenous transplacental
dissemination of the virus is possible in all stages
of pregnancy [72].
It may be assumed äs certain that the course of
hepatitis is not influenced by either continuation
or termination of pregnancy [37]. Termination
may not halt the deterioration of a case of hepa-
titis. Permanent liver damage such äs the transition
irito a chronic form do not occur more frequently
in pregnant than in non-pregnant patients.
Acute fulminant viral hepatitis, i.e., acute yellow
liver atrophy has a very high'mortality of 50-80%
even without pregnancy. Termination of pregnancy
does not change this prognosis. It usually occurs
too late and poses an additional risk [61]. Thus,
these facts do not justify termination per se and
viral hepatitis with maybe the exception of the
extremely acute cases [75].
The prophylaxis of viral hepatitis has seen new
aspects in the past few years: For hepatitis A it
has been shown that a passive immünization with
— gammaglobulin before and after exposure de-
creased the incidence of
— hepatitis, mitigate the course and prevents death
[15]
The newly available special immune globulin with
a high content of Anti-HBs (Anti-HBsIg) [18, 58,
68] offers an effective prophylaxis against hepatitis
B following exposure and this protection may
include the neonatal period [47].
Initial experiences have been made with active
immünization against hepatitis B [46].
3.1.2 Chronic hepatitis. Cirrhosis.
Chronic hepatitis may be associated with viral
disease, drugs, or of unknown etiology. An
immune mechanism has been speculated for the
chronic hepatitis of unclear etiology [7, 78].
Clinically cases are divided into chronic persistent
hepatitis with a benign course and a chronic active
and chronic aggressive hepatitis with often pro-
gressive course into cirrhosis.
While the course of chronic persistent hepatitis
during pregnancy is not different this is not
necessarily true for chronic aggressive hepatitis,
and it may vary noticably in individual cases [23].
Various authors have reported an increase in the
incidence of chronic aggressive hepatitis with cirr-
hosis in relatively young age ranges [40, 51]. Thus,
cases with cirrhosis during pregnancy may increase
inthefuture [51].
To date it has been rather rare that a patient with
cirrhosis conceived because the disease usually
occurred after menopause. Even cirrhotic patients
during the reproductive age rarely become pre-
gnant because the disturbed estrogen metabolism
leads to secondary infertility in anpvulatory cycles.
J. Perinat. Med. 7 (1979)
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Indeed, pregnancy in a cirrhotic patient may in-
dicate sufficient liver function [38]. While wome
authors report a deterioration of the cirrhosis
during pregnancy [22, 32], others have not seen a
difference on the long-term prognosis and even
improvement of the liver function has been noted
[38,51,59,77]. The principal risk for the pregnant
patient is hematemesis in the presence of portal
hypertension and possible gastro-esophageal reflux
esophagitis. The prognosis of mother and child is
determined by the complications of liver cirrhosis
(portal hypertension, ascites, hepatic coma) [39].
About 20% of pregnant patient with cirrhosis
experience liver failure [37].
Because of the complications a close contact
between obstetrician and hepatologist is necessary,
especially with chronic aggressive hepatitis and even
more well with liver cirrhosis in order to discuss
the question of continuation or termination of the
pregnancy. Each case must be analyzed individually.
Immunosuppressive therapy during pregnancy
should be discontinued because of the possible
effects on the fetus [51, 77].
Steroid treatment of chronic active hepatitis may
be continued during pregnancy [51]. However, the
assessment of estriol values for the surveillance of
the fetal-placental unit is impaired with this
medication. In chronic forms of hepatitis and with
cirrhosis prematurity (up to 50%), stillbirths (up
to 20%) and also neonatal mortality is increased äs
aconsequenceof the high prematurity rate [38,39,
40]. The rate of hypotrophic infants is also in-
creased [39]. Perinatal mortality of mature infants,
however, is not increased [37]. Surviving infants
do not have liver damage [51] and the rate of mal-
formations is not increased [37, 24], but the rate
of abortions is [38, 39]. Delivery under anesthesia
which causes stress for the liver, e.g. halothane,
should be avoided; regional anesthesias are the
alternatives.
Because of thelackofcoagulationfactors in cirrhotic
conditions there may be considerable hemorrhages
during the third stage [51].
Chronic aggressive hepatitis and compensated liver
cirrhosis pose relative indications for termination
of pregnancy while decompensated liver cirrhosis
with ascites, esophageal varices, hemorrhages, and
early coma, the termination is absolutely indicated.
It should be carried out with the least stressful
method[61].
Because of the identical Symptoms primary bilious
cirrhosis is often confused with the recurring intra-
heptic cholestasis of pregnancy [51]. In bilious
cirrhosis the p'rematurity rate and thus perinatal
mortality is increased äs well. However, the course
of the disease is not influenced by pregnancy [61].
3.1.3 Rare forms of icterus
3. l .3.1 Drug-induced jaundice
Numerous cases of jaundice, including those during
pregnancy, can be explained by various drugs
(antihistamines, antimetics, sedatives, tuberculo-
statics, halothane, etc.) [37]. Many of these sub-
stances are indirect hepatotoxic which cause liver
changes in only a small percent of exposed indi-
viduals äs an idiosyncrasy. Their action is inde-
pendent of the dose and occurs after varying
duration of the administration. Evidently pre-
disposing factors in the individuals play a role [10].
Morphologie changes in the liver vary greatly [62].
Cases of drug jaundice do not differ in their course
or severity during pregnancy [83].
3. l .3.2 Extrahepatic cholestasis
Gall stones and subsequent extrahepatic ob-
structive jaundice does not occur during pregnancy
any more frequently than in non-pregnant patients,
nor are Symptoms and therapy different [37]. This
is also true for inflammatory changes of the bile
ducts.
3. l .3.3 Functional hyperbilirubinemia
In functional disturbances of the bilirubin met-
abolism with hyperbilirubinemia (Tab. VI [76]; of
obstetrical interest only groups Ic, 2a, 2b) the
complaints increase during pregnancy. Often mild
subclinical hyperbilirubinemia become clinically
manifest during intercurrent illness, trauma, al-
cohol abuse, surgery, oral contraceptives, or preg-
nancy.
There is no treatment for these congenital hyper-
bilirubinemias regardless of the presence or absence
J. Perinat. Med. 7(1979)
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Tab. VI. Forms of congenital non-hemolytic hyperbili-
rubinemia(76J
I. Increased unconjugated bilirubin:
a. severe hyperbilirubinemia: CRIGLER-NAJJAR
Syndrome Type I
b. moderate to severe hyperbilirubinemia: CRIGLER-
NAJJAR Syndrome Type II
c. mild hyperbilirubinemia: GlLBERT's Syndrome
U. Elevation of unconjugated and conjugated bilirubin
a. with pigment deposits in the hepatocytes: DUBIN
JOHNSON Syndrome
b. without pigment deposition in the hepatocytes:
ROTOR Syndrome
III. With elevation of unconjugated and conjugated bili-





\ b. malignant course (cirrhosis):
Type CLAYTON-JUBERG (BYLER'S disease)
of pregnancy. There is usually no maternal in-
dication for termination of pregnancy. Because of
the increased jaundice the rate of prematurity may
be slightly increased. Thusfar, about 30 cases of
pregnancy in DUBIN JOHNSON syndrome have
beendescribed[3,19].
GILBERT'S disease, a relatively harmless metabolic
anomaly with slight increase of unconjugated bili-
rubin up to maximally 5 mg%, is not influenced by
pregnancy and nor does it have an effect upon the
pregnancy.
3. l .3.4 Hemolytic jaundice
While jaundice usually indicates liver involvement,
it may occur without impaired liver function. Thus,
there is usually a mild jaundice in the congenital
and acquired hemolytic anemias;primarily the un-
conjugated bilirubin is increased [37].
The association of pregnancy and hemolytic
anemia in most cases is a serious complication and
termination is indicated in many cases.
It must be taken into account that many forms of
hemolytic anemia deteriorate progressively during
pregnancy and that severe hemolytic crises may
occur [35], especially in the third trimester and
during birth. These correlations have been especially
well studied in sickle cell anemia. Pregnancy with
this disease is a severe stress with a high maternal
[10] and infant mortality (50%) äs a consequence
of the high prematurity rate [25]. During the
deterioration caused by the pregnancy of these
hemolytic anemias there is an increased tendency
for thrombosis, leading to placental infarction and
abruptio. Sickle Cell anemia is an indication for
termination of pregnancy äs is hereditary sphero-
cytosis and the thalassemias.
3.1.3.5 Qther forms of jaundice
Jaundice may occur in the course of complications
of pregnancy associated with disseminated intra-
vascular coagulation (endotoxin shock) or in
septicemia with severe pyelonephritis. This has to
be separated from jaundice with primary liver
disease or bile duct disease [37].
Fortunately, the association between pregnancy
and liver cell carcinoma is rare, but it is an absolute
indication for termination of pregnancy since
metastases into the fetus may occur [61 ]. Individual
cases of pregnancy with liver tumors have been
described[51].
3.2 Icterus e graviditate
3.2.1 Intrahepatic cholestasis of pregnancy (idio-
pathic jaundice of pregnancy)
This syndrome has been described under many
Synonyms in the literature [37]. In the pronounced
form there is a visible jaundice and in the moderate
variations there is generalized pruritus during
pregnancy [37]. Next to viral hepatitis it is the
second most common form of jaundice during
pregnancy with about 20% [49]. The disease is
observed in about 1:500 to 1:10,000 cases [22,
37, 49]. General health is only slightly impaired.
The disease usually occurs after the 22nd week of
gestation, rarely äs early äs the first trimester.
Symptoms disappear shortly after delivery. These
usually reoccur more severely during a subsequent
pregnancy. The lead Symptom is the generalized
pruritus, especially on the trank and extremities.
The jaundice is rarely severe. Bilirubin levels rarely
exceed 5-8 mg% and are predominately direct
reacting (conjugated) bilirubin and they become
J. Perinat. Med. 7 (1979)
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normal during the postpartum days. Changes
typical for cholestasis are seen in laboratory tests.
Transaminases are slightly elevated, rarely above
300 units [42], Histological examinations of liver
biopsies in the light microscope demonstrate hepatic
stasis with bile thrombi in the dilated bile canali-
culi, especially around the central veins. There are
no inflammatory reactions or indications of pro-
liferation of mesenchymal cells [37].
The etiology of this disease is not completely
understood [49, 51]. Probably it is a disturbance
in the estrogen metabolism with a familiär
disposition [37, 51], which becomes manifest
during pregnancy or with the use of estrogen·
containing contraceptives. The illness is harmless
for the pregnant patient.
Reports on the prognosis for the child vary. A
rate of prematurity of up to 40% explains the
high perinatal mortality reported by some [29,37,
49,77].
There is no specific treatment and termination of
pregnancy is not indicated [61]. The pruritus may
be aleviated with the use of cholestyramine, a non-
resorbable alkaline synthetic resin which binds bile
salts in the intestine [49], This Interrupts the entero-
hepatic circulation and the bile acids in the serum
fall äs a consequence. It is clinically important to
rule out viral hepatitis in the differential diagnosis.
3.2.2 Acute fatty liver of pregnancy
This is a fortunately rare, yet very severe, disease
described first by STANDER and CRADDEN in
1934 [64]. The etiology is unknown. The disease
usually begins very actuely in the 36 th to 40th
week of gestation [37]. First signs, even before
nausea and vomiting, are lethargy, depressive mood
changes, and psychotic signs. In addition there are
frequently neurological Symptoms. This psychotic
phase which may precede the other Symptoms for
up to 14 days is considered the typical initial sign
of the disease [64]. This may be confused with the
equally rare pregnancy psychoses.
Later severe headache, intractable vomiting,
— initially bilious, later coffee-ground — äs well äs
abdominal pain. Among the severe problems are
acute hemorrhages into the gastrointestinal tract,
kidney, central nervous System, äs well äs the
development of disseminated intravascular co-
agulopathy. Ultimately, oligouria or anuria occur
äs well äs stupor and coma. The clinical course
resembles that of the acute liver necrosis in viral
hepatitis with the corresponding laboratory
fmdings [37], There are 118 cases reported in the
literature [64]. Histologically characteristic is a
picture of fatty changes at the central veins, with
swollen, foamy and packed hepatocytes. The cyto-
plasm is displaced with numerous small vacuoles
[37].
Therapy of fatty liver pregnancy is symptomatic.
It includes [64]:
1. termination of pregnancy
2. treatment of hepatic coma
3.correction of imbalance in the metabolism of
glucose, fluids, electrolytes and acid-base
4. treatment of coagulopathy
These intensive measures have decreased the
mortality of this disease during the last ten years
from80%to45%[64].
3.2.3 Toxemia of pregnancy
Some women with toxemia of pregnancy have
jaundice during the course of hyperemesis gravi-
darum or eclampsia. These forms of jaundice con-
stitute accompanying Symptoms of the underlying
toxemia. A specific therapy of this firm of icterus
is not possible nor is it necessary since the jaundice
will disappear together with the underlying toxemia.
4 Liver disease and termination of pregnancy
Tab. 7 reviews indications for termination of
pregnancy in relative and absolute terms according
to literature data. Thus, there is an absolute
indication with
1. acute fatty liver of pregnancy,
2. decompensated liver cirrhosis,
S.livercarcinoma
Relative indications are:
1. chronic aggressive hepatitis,
2. compensated liver cirrhosis,
3. primary bilious cirrhosis,
4. some hemoloytic anemias
J. Perinat. Med. 7(1979)
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5. some rare congenital diseases (WILSON'S disease
or hepatic porphyria)
Questionable is termination with acute viral
hepatitis, because the extent of the possible
chromosome damage from the virus has not been
well defined.
5 Discussion
The discussion of liver disease during pregnancy
must emphasize the Separation of liver diseases
caused by liver diseases specific to the pregnant
state from those who occur also outside of preg-
nancy. Because of the problems with the differ-
ential diagnosis of infectious hepatitis from other
diseases presenting with jaundice it is justified to
isolate each patient with jaundice until an in-
fectious process has been ruled out.
Since any icteric disease in pregnancy without
regard to etiology and pathogenesis is also a
considerable risk for the infant, the prenatal
surveillance of the fetus must be intense. The
question of the necessity for tocolysis with
premature onset of labor because of the liver
disease must be decided on an individual basis.
Human placental lactogen äs an indicator of pla-
cental function is not influenced'by liver disease.
The assay of estriol excretion in the urine or of
serum estriol levels is not influenced äs long äs
radio-immune assays are used in contrast to
colorimetry [37]. Thus, an existing jaundice does
not prevent the use of these parameters for
monitoring the intrauterine fetal well-being.
Keywords: Cholestasis of pregnancy, cirrhosis, fatty liver of pregnancy, liver function during normal pregnancy,





Beim Zusammentreffen von Lebererkrankung und Schwan-
gerschaft interessieren zwei Fragen:
l. Wie wird die erkrankte Leber durch die Schwangerschaft
beeinflußt?
2. Welche Auswirkungen hat die Lebererkrankung auf die
Schwangerschaft?
Diese beiden Fragen sollen an Hand der vorliegenden Lite-
ratur beantwortet werden.
Eine normale Schwangerschaft stellt bereits für eine ge-
sunde Leber eine erhebliche funktioneile und metabo-
J. Perinat. Med. 7 (1979)
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lische Mehrbelastung dar. Dieses findet seinen Ausdruck
in zahlreichen von der Norm abweichenden biochemi-
schen Befunden (Tab. I).
Die Serumenzyme lassen während der Schwangerschaft
typische Veränderungen erkennen (Tab. II).
Jede mit Ikterus einhergehende Erkrankung kann auch
während der Schwangerschaft auftreten (Icterus in
graviditate). Daneben gibt es Ikterusfälle als Folge der
Schwangerschaft (Icterus e graviditate).
Die Ikterushäufigkeit bei Schwangeren liegt bei 0,2-
l»8°/oo. Ikterus in der Schwangerschaft ist also ein relativ
seltenes Symptom.
Eine Übersicht über die Häufigkeit der verschiedenen
Ikterusformen ist aus der Tab. III zu entnehmen.
Tab. IV gibt eine Systematik der mit Ikterus einherge-
henden Erkrankungen während der Schwangerschaft.
Die akute Virushepatitis stellt die häufigste Form einer
Lebererkrankung während der Schwangerschaft dar.
Tab. V gibt eine Übersicht über die verschiedenen Hepa-
titiserreger. Die Empfänglichkeit für eine akute Hepatitis
ist bei der Schwangeren nicht höher als bei der Nicht-
schwangeren. Auch der Verlauf scheint in der Schwanger-
schaft nicht anders als außerhalb der Schwangerschaft zu
sein.
Die Infektionswege der Hepatitis auf das Kind sind viel-
fältig; eine diaplazentaie Übertragung ist als gesichert an-
zusehen.
Das Risiko für eine neonatale Infektion wird umso größer,
je näher die Hepatitisinfektion der Mutter am Entbin-
dungstermin Hegt.
Über die Aborthäufigkeit und die Totgeburtenrate liegen
unterschiedliche Angaben vor. Einstimmigkeit herrscht
darüber, daß die Frühgeburtenrate auf 15-35% erhöht
ist. Die Rate der intrauterinen Mangelentwicklungen ist
bei der akuten Hepatitis nicht erhöht. Die Mißbildungs-
häufigkeit ist nicht vermehrt. Ob fetale Chromosomen-
schäden bei der akuten Hepatitis auftreten und geburts-
hilflich von Bedeutung sein können, ist noch nicht zwei-
felsfrei bewiesen.
Die akute Virushepatitis stellt insgesamt gesehen keine
Indikation zum Schwangerschaftsabbruch dar.
Das gleichzeitige Vorkommen von chronischer Hepatitis
und Zirrhose einerseits und einer Schwangerschaft an-
dererseits ist ein seltenes Ereignis. Während die persi-
stierende Form der chronischen Hepatitis in der Schwan-
gerschaft keinen besonderen Verlauf nimmt, ist das bei
der chron.-aggressiven Hepatitis unterschiedlich. Auch
der Zirrhoseverlauf kann während der Schwangerschaft
sehr unterschiedlich sein. Die Hauptgefahr für die Schwan-
gere besteht bei den chronischen Verlaufsformen in der
Hämatemesis bei bereits vorbestehender portaler Hyper-
tension.
Bei den chronischen Hepatitiden und der Zirrhose ist die
Frühgeburtenrate (bis 50%), die Totgeburtenfrequenz
(bis 20%) und auch die postpartale Sterblichkeit erhöht.
Die Mißbüdungsrate ist nicht erhöht, wohl aber die Abort-
frequenz.
Die selteneren Ikterusformen wie Medikamentenikterus,
extrahepatische Cholestase und die funktioneilen Hyper-
bilirubinämien (Tab. VI) zeigen während der Schwanger-
schaft keinen besonderen Verlauf. Eine Indikation zur
Abruptio ist in diesen Fällen nicht gegeben.
Von den mit Ikterus einhergehenden hämolytischen
Anämien können einige in der Schwangerschaft eine pro-
grediente Verschlechterung erfahren und zu hämolyti-
schen Krisen führen. Eine Indikation zum Schwanger-
schaftsabbruch ist oft gegeben. Die intrahepatische
Schwangerschaftscholestase oder der idiopathische
Schwangerschaftsikterus ist die zweithäufigste Ikterus-
form in der Schwangerschaft. Die Ätiologie dieser für die
Mutter harmlosen Erkrankung ist noch nicht vollständig
geklärt. Die kindliche Prognose ist durch eine Früh-
geburtenrate bis 40% getrübt. Eine Indikation zur Ab-
ruptio ist nicht gegeben.
Die akute Schwangerschaftsfettleber ist ein glücklicher-
weise seltenes, jedoch schwerstes Krankheitsbild. Bisher
sind in der Literatur 118 Fälle beschrieben worden.
Diese Schwangerschaftskomplikation tritt erst im III.
Trimenon auf. Die Ursache der Erkrankung ist unbekannt.
Durch intensive therapeutische Maßnahmen konnte die
Sterblichkeit dieser Erkrankung von über 80% auf 45%
gesenkt werden.
Die absoluten und relativen Indikationen zum Schwan-
gerschaftsabbruch bei Lebererkrankungen sind in der
Tab. VII zusammengestellt.
Da die differentialdiagnostische Abklärung eines Ik-
terus sehr schwierig sein kann und infektiöse Erkrankun-
gen zahlenmäßig überwiegen, ist es gerechtfertigt, jede
Schwangere mit Ikterus so lange zu isolieren, bis der Be-
weis erbracht ist, daß es sich nicht um ein infektiöses
Geschehen handelt.
Schlüsselwörter: Leberfunktion in der normalen Schwangerschaft, Schwangerschaftscholestase, Schwangerschaftsfett-
leber, Schwangerschaftsabbruch bei Lebererkrankungen, Virushepatitis, Zirrhose.
Resume
Fonction et maladies hepatiques en cours de grossesse
La coincidcnce de maladie du foie et de grossesse souleve
les deux principales questions suivantes:
l.Dans quelle mesure la grossesse joue-t-elle un röle
influent sur le foie malade?
2. Quels sont les effets de la maladie du foie sur la
grossesse?
Nous nous proposons de repondre a ces deux questions en
nous reportant a la litterature.
Une grossesse normale represente deja une Charge
fonctionnelle et metabolique supplementaire considerable
pour un foie sain, ainsi qu'il apparait dans les nombreux
resultats biochimiques s'ecartant de la norme (Tab. I).
Les enzymes du serum montrent des changements typiques
pendant la grossesse (Tab. II).
Toute maladie liee a l'ictere est possible pendant la
grossesse (icterus in graviditate). De plus, U existe des
casd'ictereconsecutifsa la grossesse (icterus e graviditate).
J. Perinat. Med. 7(1979)
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La frequence d'ictere chez les femmes enceintes est de
0,2 a 1,8%0. L'ictere en cours de grossesse est donc un
Symptome relativement rare.
Un aper^u de la frequence des diverses formes d'ictere est
donne Tab. III.
Le Tab. IV donne un classement des maladies liees a
l'ictere pendant la grossesse.
L'hepatite virale aigue representelaformela plus frequente
des maladies du foie en cours de grossesse. Le Tab' V offre
un tableau des divers agents de l'hepatite. La receptivite
pour une hepatite aigue n'est pas plus elevee chez les
femmes enceintes que chez celles non enceintes. De meme,
le deroulement de cettehepatopathienesemblepasdifferer
entre la grossesse et la non-grossesse.
Les voies infectieuses communiquant l'hepatite ä Fenfant
sont nombreuses; une transmission diaplacentaire ne
semble plus faire de doute.
Le risque d'une infection neonatale est d'au t an t plus
grand que Hnfection hepatique de la mere est proche du
terme de l'accouchement.
Les donnees different sur la frequence des avortements
spontanes et le taux des morts-nes. Mais elles concordent
$ur l'augmentation du taux des naissances prematurees a
15-35%. Le taux des malnutritions intra-uterines n'est'
pas plus eleve dans les cas d'hepatite aigue. II en est de
meme pour la frequence des malformations. La question
concernant l'apparition de lesions chromosomiques
foetales en cas d'hepatite aigue et de leur importance en
obstetrique reste encore en suspens. L'hepatite virale
aigue ne comporte d'une faqon generale aucune indication
d'interruption de grossesse.
L'apparition simultanee d'hepatite chronique et de
cirrhose d'une part et d'une grossesse d'autre part est un
fait rare. Tandis que la forme persistante de l'hepatite
chronique dans la grossesse ne suit pas un cours particulier,
il peut en aller autrement pour l'hepatite chron.-agressive.
De meme, l'evolution de la cirrhose peut etre tres
differenciee pendant la grossesse. Le risque principal
encouru par la femme enceinte est cause par les formes
evolutives chroniques de l'hematemese en cas d'hyper-
tension portale deja presente. · f
Dans les hepatites chroniques et la cirrhose, le taux des
naissances prematures (jusqu'a 50! ), la frequence des
morts-nes (jusqu'a 20! ) ainsi que la mortalite postpartale
sont eleves. Le taux des malformations n'augmente pas,
au contraire de celui des avortements spontanes.
Les formes plus rares d'ictere, telles que ictere medicamen-
teux, la cholestase extrahepatique et l'hyperbilirubinemie
f onctionnelle (Tab. VI) ne montrent aucun cours particulier
pendant la grossesse. Une indication d'interruption n'est
pas donnes dans ces cas.
Certaines des anemies hemolytiques avec ictere peuvent,
pendant la grossesse, subirent une aggravation progressive
et provoquer des crises hemolytiques. Une Interruption de
grossesse est souvent indiquee.
La cholestase gravidique intrahepatique ou l'ictere gravi-
dique protopathique represente ladeuxieme forme icterique
la plusfrequenteen cours de grossesse. L'etiologie de cette
maladie sans danger pour la mere n'a pas encore ete
entierement eclaircie. Le pronostic pour l'enfant reste
insatisfaisänt a cause du taux des naissances prematures
qui peut atteindre 40! . Une indication d'interruption
n'est pas donnee.
La cirrhose gravidique aigue est une forme de maladie
tres grave, heureusement rare. 118 cas ont rapportes
dans la litterature jusqu'a present. Cette complication de
la grossesse n'apparait qu'au Illeme trimestre et la cause
en est inconnue. Des mesures therapeutiques intensives
ont permis d'abaisser de plusde 80 a 45% le taux de la
mortalite düe a cette maladie.
Les indications absolues et relatives d'une Interruption de
grossesse dans les cas de maladies hepatiques ont ete
repertoriesTab.VII.
Le diagnostic differentiel d'un ictere pouvant etre tres
difficile a etablk et la proportion des maladies infectieuses
etant superieure, il apparait justifie d'isoler toute femme
enceinte atteinte d'ictere jusqu'a ce qu'on ait pu prouver
qu'il ne s'agit pas d'un cas infectieux.
Mots-cles: Cholestase gravidique, cirrhose, cirrhose gravidique, fonction hepatique dans la grossesse normale, hepatite
virale, Interruption de grossesse en cas de maladies hepatiques.
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